Tustin, CA, United States of America

Mark M Foreman



Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mark M. Foreman: Innovator in Pharmaceutical Compositions

Introduction

Mark M. Foreman is a notable inventor based in Tustin, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of composite compositions for treating anti-psychotic disorders. With a total of 3 patents, his work has the potential to impact the treatment of psychiatric and neurological diseases.

Latest Patents

Foreman's latest patents include innovative pharmaceutical composite compositions that comprise tetrahydroindolones linked to arylpiperazines. These compositions are designed to effectively ameliorate symptoms of psychotic disorders without causing cognitive impairment. The composite compounds consist of two moieties, where moiety A is a tetrahydroindolone linked through a linker to moiety B, which is an arylpiperazinyl moiety. This unique structure allows for interaction with GABA, serotonin, and dopamine receptors, providing anti-psychotic activity. Additionally, he has developed methods for synthesizing tetrahydroindolone analogues that enhance pharmacological effects and promote absorption across the blood-brain barrier.

Career Highlights

Throughout his career, Mark M. Foreman has worked with reputable companies in the pharmaceutical industry, including Spectrum Pharmaceuticals, Inc. and Neotherapeutics, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Foreman has collaborated with notable professionals in the field, including Alvin Jerald Glasky and David B. Fick. These collaborations have likely enriched his research and development efforts, leading to advancements in pharmaceutical compositions.

Conclusion

Mark M. Foreman is a distinguished inventor whose work in pharmaceutical compositions has the potential to transform the treatment of psychiatric disorders. His innovative approaches and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…